image
Ultragenyx Pharmaceutical Inc. RARE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
INCOME STATEMENT
560 M REVENUE
29.01%
Growth Rates
1Year 29.01%
3Years 16.82%
5Years 40.12%
7Years 115.31%
10Years 0.00%
-536 M OPERATING INCOME
5.84%
Growth Rates
1Year 5.84%
3Years -11.98%
5Years -4.79%
7Years -7.22%
10Years -25.17%
-569 M NET INCOME
6.17%
Growth Rates
1Year 6.17%
3Years -7.83%
5Years -7.16%
7Years -9.47%
10Years -25.27%
EFFICIENCY
Earnings Waterfall Ultragenyx Pharmaceutical Inc.
image
Revenue 560 M
Cost Of Revenue 76.7 M
Gross Profit 484 M
Operating Expenses 1.02 B
Operating Income -536 M
Other Expenses 33.2 M
Net Income -569 M

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 560.2 434.2 363.3 351.4 271.0 103.7 51.5 2.6 0.1 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 76.7 45.2 28.3 16.0 6.1 9.0 1.1 1 K 183.2 1.4 0 0 0 0
Gross Profit 483.5 389.0 335.0 335.4 264.9 94.7 50.3 2.6 (183.1) (1.4) 0 0 0 0
OPERATING INCOME
Operating Expenses 1 019.5 958.2 983.9 717.1 595.0 518.9 421.7 331.6 248.1 147.7 56.8 32.3 16.0 6.6
Selling, General and Administrative Expenses 321.6 309.8 278.1 220.0 182.9 161.5 127.7 99.9 64.9 33.0 10.8 4.5 3.3 1.8
Research and Development Expenses 697.9 648.4 705.8 497.2 412.1 357.4 294.0 231.6 183.2 114.7 46.0 27.8 12.6 4.7
Operating Income (536.0) (569.2) (648.9) (381.7) (330.1) (424.2) (371.4) (328.9) (248.0) (147.7) (56.8) (32.3) (16.0) (6.6)
PRE-TAX INCOME
Interest Income Expense (63.0) 66.0 43.0 29.4 33.3 1.1 0 0 0 0 0 0 0 0.3
Total Other Income (31.6) (39.3) (52.8) (71.2) 144.8 24.7 174.3 10.6 2.2 2.1 (3.0) (2.8) (0.3) (0.3)
Pre-Tax Income (567.6) (608.5) (701.7) (453.0) (185.4) (399.4) (197.1) (318.3) (245.8) (145.6) (59.8) (35.1) (16.3) (6.8)
NET INCOME
Tax Provision (1.6) (1.8) 5.7 1.0 1.2 3.3 0.5 (16.2) 35 K (2.3) (0.7) (3.0) (0.3) 0.2
Net Income (569.2) (606.6) (707.4) (454.0) (186.6) (402.7) (197.6) (302.1) (245.9) (145.6) (59.8) (35.1) (16.3) (6.8)
EPS 6.29 8.25 10.1 6.7 3.07 7.12 3.97 7.12 6.21 3.96 2.08 1.21 0.71 0.3